**Exhibit 99-1**

 
|                       |  |
|----------------------------|--|
| Angeion  Corporation       |
| 350 Oak Grove Parkway      |
| St. Paul, MN 55127 USA     |
| Telephone: (651) 484-4874  |
| Facsimile:  (651) 484-4826 |

 

**FORIMMEDIATE RELEASE**

 
| **Contacts:** | Rodney A. Young, President  and Chief Executive Officer, (651) 484-4874 |
|---------------|-------------------------------------------------------------------------|
|          | Dale H.  Johnson, Chief Financial Officer, (651) 484-4874               |

 

**Angeion Regains Compliancewith NASDAQ Listing Standards**

 

**SAINT PAUL,Minn. (September 7, 2005) —**Angeion Corporation (**NASDAQ SC:ANGN**) announced today that in a letter dated September 2, 2005,the NASDAQ Listing Qualifications Department staff advised that Angeion has nowmet the revised NASDAQ listing requirements and that a NASDAQ Stock Market de-listinghearing would not be necessary.

 

NASDAQ staff hadpreviously advised Angeion that it was not in compliance with the independentdirector requirements of NASDAQ that call for at least three independentdirectors.  NASDAQ previously determinedthat Angeion’s Board of Directors consisted of four individuals, only two ofwhom were independent, thus falling outside this NASDAQ requirement.  Immediately after receiving the NASDAQ de-listingletter, Angeion notified NASDAQ that it had already initiated efforts to add anadditional independent director to its Board of Directors, and that the Companywould accelerate those efforts.

 

On August 30,2005, K. James Ehlen, M.D. joined Angeion’s Board of Directors.  The Company subsequently notified NASDAQ ofthe addition of a qualified, independent director to its Board of Directors, promptingNASDAQ to remove Angeion from the formal hearing process.

 

Rodney A. Young,President and Chief Executive Officer of the Company, commented, “We arepleased to have been promptly notified by NASDAQ that we are now in compliancewith this revised NASDAQ requirement. Through accelerating our board nomination process, Angeion Corporation nowhas additional experience and expertise within our Board of Directors.”

 

Founded in1986, Angeion Corporation acquired Medical Graphics (www.medgraphics.com) inDecember 1999.  Medical Graphicsdevelops, manufactures, and markets non-invasive cardiorespiratory diagnosticsystems for the management and improvement of cardiorespiratory health.  The Company has also introduced a line ofhealth and fitness products, many of which are derived from Medical Graphics’cardiorespiratory product technologies. These products, marketed under the New Leaf health and fitness brand(www.newleaf-online.com), help consumers effectively manage their weight andimprove their fitness.  They are marketedto the consumer primarily through personal training studios, health and fitnessclubs and other exercise facilities.  Formore information about Angeion, visit www.angeion.com.

**-more -**

 

----

 

The discussion above contains forward-lookingstatements within the meaning of the Private Securities Litigation Reform Actof 1995.  These statements by theirnature involve substantial risks and uncertainties.  Actual results may differ materially dependingon a variety of factors, including (i) the Company’s ability to successfullydevelop, improve and update its cardiorespiratory diagnostic products, (ii) theCompany’s ability to successfully introduce its New Leaf health and fitnessproducts, (iii) the Company’s ability to achieve and maintain a level ofrevenue that enables it to attain profitability, (iv) the Company’sability to successfully defend itself from product liability claims related toits Medical Graphics’ products and claims associated with its prior cardiacstimulation products, v) the Company’s ability to successfully conclude itslitigation against Medmarc Casualty Insurance Company concerning the Company’sproduct liability insurance coverage; (vi) the Company’s ability toprotect its intellectual property, and (vii) the Company’s dependence onthird-party vendors.  Additionalinformation with respect to the risks and uncertainties faced by the Companymay be found in, and the prior discussion is qualified in its entirety by, theother risk factors that are described from time to time in Angeion’s Securitiesand Exchange Commission reports, including but not limited to the Annual Reporton Form 10-KSB for the year ended October 31, 2004, and subsequentlyfiled reports.

 

# # #

 

----